Charles Roco
Charles Roco is Co-Founder and CTO at Parse Biosciences. He previously served as a Graduate Research Assistant at University of Washington Bioengineering and held research roles in drug delivery, microbiology, and cell mechanics at institutions including Harvard, Wyss Institute, Virginia Tech, and University of Pennsylvania.
Parse Biosciences and Nomic Bio launch Cascade: 100M-cell dataset pairing RNA-seq with 1,000-protein secretome across 150,000+ immune perturbations, backed by GSK, Pfizer, Sanofi
Parse Biosciences and Nomic Bio launched Cascade, a consortium-backed 100-million-cell immune perturbation dataset linking single-cell transcriptomes with matched 1,000-plex secretome protein reads across 150,000+ conditions to add protein signaling data that prior transcriptomics-only resources lacked.
Seattle’s UW research, Amazon alumni and military adjacency fuel startups building high-stakes, regulation-ready AI for biotech, finance and government
A Seattle high-school intern argues that strict school AI rules illuminated why AI must be disciplined in high-stakes domains, and describes how Seattle's research institutions (notably UW and the David Baker ecosystem), Amazon alumni, and military adjacency produce founders building accountable, regulation-ready AI for biotech, finance, and government.
Qiagen to Acquire Seattle’s Parse Biosciences for $225 Million in Cash Deal Closing December 2023
Seattle's Parse Biosciences, a single-cell RNA sequencing company founded in 2018, is being acquired by Netherlands-based Qiagen in a $225 million cash deal expected to close in December. Parse, which serves 3,000 customers globally and raised over $50 million in funding, will continue operating from its Seattle headquarters as a Qiagen subsidiary.
See all 9 stories, episodes and videos about Charles Roco.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events
Organizations
See all 9-
Parse Biosciences CTO and Cofounder 2018–present · current
-
Split Biosciences Executive Officer, Director, Promoter 2018 · past
-
University of Washington Bioengineering Graduate Research Assistant 2015–2019 · past
Education
-
University of Washington Doctor of Philosophy - PhD, Bioengineering · 2015–2019
-
Virginia Tech Bachelor of Science (B.S.), Biological Systems Engineering · 2011–2015